JP2023544199A5 - - Google Patents
Info
- Publication number
- JP2023544199A5 JP2023544199A5 JP2023521067A JP2023521067A JP2023544199A5 JP 2023544199 A5 JP2023544199 A5 JP 2023544199A5 JP 2023521067 A JP2023521067 A JP 2023521067A JP 2023521067 A JP2023521067 A JP 2023521067A JP 2023544199 A5 JP2023544199 A5 JP 2023544199A5
- Authority
- JP
- Japan
- Prior art keywords
- inhibitors
- population
- optionally
- nsclc
- til population
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063127027P | 2020-12-17 | 2020-12-17 | |
| US63/127,027 | 2020-12-17 | ||
| US202163146402P | 2021-02-05 | 2021-02-05 | |
| US63/146,402 | 2021-02-05 | ||
| USPCT/US2021/053841 | 2021-10-06 | ||
| PCT/US2021/053841 WO2022076606A1 (en) | 2020-10-06 | 2021-10-06 | Treatment of nsclc patients with tumor infiltrating lymphocyte therapies |
| PCT/US2021/055304 WO2022076952A1 (en) | 2020-10-06 | 2021-10-15 | Treatment of nsclc patients with tumor infiltrating lymphocyte therapies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023544199A JP2023544199A (ja) | 2023-10-20 |
| JP2023544199A5 true JP2023544199A5 (enExample) | 2024-10-23 |
Family
ID=86282189
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023521067A Pending JP2023544199A (ja) | 2020-12-17 | 2021-10-15 | 腫瘍浸潤リンパ球療法によるｎｓｃｌｃ患者の治療 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP2023544199A (enExample) |
| CA (1) | CA3195023A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2023546359A (ja) * | 2020-10-06 | 2023-11-02 | アイオバンス バイオセラピューティクス，インコーポレイテッド | 腫瘍浸潤リンパ球療法によるｎｓｃｌｃ患者の治療 |
| CN115927303A (zh) * | 2022-07-13 | 2023-04-07 | 南京鼓楼医院 | TBL1XR1基因及其gRNA在制备提升T细胞功能药物中的应用 |
| CN115944650B (zh) * | 2023-01-03 | 2023-11-28 | 青岛大学 | 肿瘤浸润细胞在制备抗肿瘤药物中的应用及模型构建方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202031273A (zh) * | 2018-08-31 | 2020-09-01 | 美商艾歐凡斯生物治療公司 | 抗ｐｄ－１抗體難治療性之非小細胞肺癌（ｎｓｃｌｃ）病患的治療 |
-
2021
- 2021-10-15 CA CA3195023A patent/CA3195023A1/en active Pending
- 2021-10-15 JP JP2023521067A patent/JP2023544199A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023546359A5 (enExample) | ||
| Qiu et al. | Exploring the emerging role of the gut microbiota and tumor microenvironment in cancer immunotherapy | |
| JP2022512899A5 (enExample) | ||
| JP2023544199A5 (enExample) | ||
| JP2024501452A5 (enExample) | ||
| JP2021535128A5 (enExample) | ||
| Rivera Vargas et al. | Can immunogenic chemotherapies relieve cancer cell resistance to immune checkpoint inhibitors? | |
| Bhoopathi et al. | The quest to develop an effective therapy for neuroblastoma | |
| TWI895295B (zh) | 偵測編碼新生抗原之融合基因之方法 | |
| FI3843759T3 (fi) | Tuumoriin filtroituvien lymfosyyttien käyttö anti-PD-1-vasta-aineelle vastustuskykyisten NSCLC-potilaiden hoitoon | |
| Lotzová et al. | Natural killer cells in mice and man and their possible biological significance | |
| JP2024510505A5 (enExample) | ||
| KR20180041229A (ko) | 줄기 세포 이식을 위한 방법 | |
| TWI741731B (zh) | 一種含西達本胺的抗腫瘤藥物組合物及其應用 | |
| JP2023554395A5 (enExample) | ||
| US20220378890A1 (en) | Immunogenic egfr peptide compositions and their use in the treatment of cancer | |
| Plaugher et al. | Therapeutic potential of tumor-infiltrating lymphocytes in non-small cell lung cancer | |
| JP2025512313A5 (enExample) | ||
| Huang et al. | Tumor immunotherapy: past, present, and future | |
| Carbone et al. | In vitro detection of cell‐mediated immunity to individual tumor‐specific antigens of chemically induced BALB/c fibrosarcomas | |
| CN113116895B (zh) | 用于治疗神经母细胞瘤的喹啉衍生物 | |
| Chang et al. | Immunotherapy with sensitized lymphocytes | |
| WO2021143799A1 (zh) | 抗pd-1抗体和呋喹替尼联合在制备治疗癌症的药物中的用途 | |
| Sacks et al. | A clinical trial of chemotherapy and RAJI immunotherapy in advanced acute lymphatic leukemia | |
| JPH08510131A (ja) | 癌およびウイルス性疾患を治療するための改変化ｔａｌｌ−１０４細胞の使用 |